Data from Chinese Academy of Sciences Advance Knowledge in Lung Cancer (HIF-1a-HPRT1 axis promotes tumorigenesis and gefitinib resistance by enhancing purine metabolism in EGFR-mutant lung adenocarcinoma).

Předmět:
Zdroj: Clinical Oncology Week; 10/22/2024, p270-270, 1p
Abstrakt: A recent study from the Chinese Academy of Sciences explores the role of the HIF-1a-HPRT1 axis in promoting tumorigenesis and gefitinib resistance in EGFR-mutant lung adenocarcinoma. The research reveals that mutated EGFR upregulates HPRT1 to enhance purine metabolism, leading to rapid tumor cell proliferation. The study suggests that inhibiting purine metabolism could be a potential strategy for treating EGFR-mutant lung adenocarcinoma. [Extracted from the article]
Databáze: Complementary Index